(Total Views: 625)
Posted On: 03/30/2022 9:34:54 PM
Post# of 154012
"mostly immaterial, though injurious to those patients forced to switch to toxic cocktails."
CTMedic, This reminds me of another good thing about Leronlimab in the arena of HIV. We don't counteract or lessen the effectiveness of previous treatments. A patient can return to a previous treatment and not be affected by the use of LL. At some point in the late 2010's we had to prove that to carry on with further studies.
Not very germane to the next 11 hours, but still...ROCK ON!
CTMedic, This reminds me of another good thing about Leronlimab in the arena of HIV. We don't counteract or lessen the effectiveness of previous treatments. A patient can return to a previous treatment and not be affected by the use of LL. At some point in the late 2010's we had to prove that to carry on with further studies.
Not very germane to the next 11 hours, but still...ROCK ON!
(1)
(0)
